Silence Therapeutics (SLN) Current Deferred Revenue (2019 - 2025)
Silence Therapeutics recorded quarterly Current Deferred Revenue of $168000.0 in Q4 2025, down 44.19% quarter-over-quarter from $301000.0 in Q3 2025, and down 45.1% year-over-year from $306000.0 in Q4 2024.
Silence Therapeutics' Current Deferred Revenue history runs 7 years deep, the most recent figure standing at $168000.0 for Q4 2025.
- In Q4 2025, Current Deferred Revenue fell 45.1% year-over-year to $168000.0; the TTM figure through Dec 2025 stood at $168000.0 (down 45.1% YoY), while the FY2025 annual figure was $168000.0, down 45.1% from the prior year.
- Current Deferred Revenue came in at $168000.0 for Q4 2025 at Silence Therapeutics, down from $301000.0 in the prior quarter.
- In the past five years, Current Deferred Revenue ranged from a high of $10.4 million in Q4 2022 to a low of $168000.0 in Q4 2025.
- A 5-year average of $3.0 million and a median of $424500.0 in 2025 frame the typical range for Current Deferred Revenue.
- Across the five-year window, Current Deferred Revenue soared 81.6% in 2022 and plunged 95.22% in 2024, its largest moves.
- Silence Therapeutics' Current Deferred Revenue stood at $5.7 million in 2021, then jumped by 81.6% to $10.4 million in 2022, then sank by 38.39% to $6.4 million in 2023, then sank by 95.22% to $306000.0 in 2024, then tumbled by 45.1% to $168000.0 in 2025.
- According to Business Quant data, Current Deferred Revenue over the past three periods registered $168000.0, $301000.0, and $457000.0 for Q4 2025, Q3 2025, and Q2 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn |
| 10 | Silence Therapeutics | 924.61 Mn | 854.53 Mn | 411,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 168,000.00 |
| Sep 30, 2025 | 301,000.00 |
| Jun 30, 2025 | 457,000.00 |
| Mar 31, 2025 | 392,000.00 |
| Dec 31, 2024 | 306,000.00 |
| Dec 31, 2023 | 6.41 Mn |
| Dec 31, 2022 | 10.40 Mn |
| Dec 31, 2021 | 5.73 Mn |
| Dec 31, 2020 | 22.50 Mn |
| Dec 31, 2019 | 3.19 Mn |